NCT07858097Not yet recruiting
Bethesda Classification and Risk Stratification in Differentiated Thyroid Carcinoma
Relationship Between Preoperative Fine Needle Aspiration Cytology (Bethesda Classification) and Postoperative Risk Stratification in Patients With Differentiated Thyroid Carcinoma
Source: ClinicalTrials.gov · Last updated 5 Oct 2026
Brief summary (registry, in English)
This observational study aims to evaluate the relationship between preoperative Bethesda classification of fine-needle aspiration cytology and postoperative American Thyroid Association (ATA) risk stratification in patients with differentiated thyroid carcinoma.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 20 Aug 2026
- Start date
- 26 Oct 2026
- Primary completion date
- 25 Oct 2027
- Lead sponsor
- Assiut University
- Diseases
- Thyroid cancer
- NCT number
- NCT07858097
What you commit to
- Study type: Observational
- Planned participants: 100
- From 26 Oct 2026 to the primary completion date, 25 Oct 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Poorly differentiated thyroid carcinoma
- Anaplastic thyroid carcinoma
- Medullary thyroid carcinoma
- Non-diagnostic FNAC (Bethesda category I)
- Inadequate follow-up data
Who the study is looking for
- Age ≥ 18 years
- Available preoperative fine-needle aspiration cytology (FNAC)
- Postoperative histopathologically confirmed differentiated thyroid carcinoma
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.